Efficacy of Antiviral Therapy After Radical Resection for Hepatitis B Virus-Related Hepatocellular Carcinoma

NCT00768157 · clinicaltrials.gov ↗

PHASE4

Phase

UNKNOWN

Status

200

Enrollment

OTHER

Sponsor class

Conditions

Hepatocellular Carcinoma
Hepatitis B Virus
Recurrence

Interventions

DRUG: antiviral treatment (lamivudine or entecavir)
PROCEDURE: radical resection of HBV-related HCC

Sponsor

Sun Yat-sen University